Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robberecht

Showing results (561-570 of 651) with videos related to

Pageof 66
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|September 7, 2007
Astrocytes regulate GluR2 expression in motor neurons and their vulnerability to excitotoxicityPhilip Van Damme, Elke Bogaert, Maarten Dewil, et al.
Brain Communications|May 12, 2021
Intracerebroventricular delivery of vascular endothelial growth factor in patients with amyotrophic lateral sclerosis, a phase I studyPhilip Van Damme, Petra Tilkin, Katarina Jansson Mercer, et al.
Alzheimer'S Research & Therapy|December 14, 2019
EphA4 loss improves social memory performance and alters dendritic spine morphology without changes in amyloid pathology in a mouse model of Alzheimer's diseaseLindsay Poppe, Laura Rué, Mieke Timmers, et al.
Inflammatory Bowel Diseases|November 24, 2015
Genome-Wide Copy Number Variation Scan Identifies Complement Component C4 as Novel Susceptibility Gene for Crohn's DiseaseIsabelle Cleynen, Peter Konings, Caroline Robberecht, et al.
Brain : a Journal of Neurology|February 8, 2018
HDAC6 is a therapeutic target in mutant GARS-induced Charcot-Marie-Tooth diseaseVeronick Benoy, Lawrence Van Helleputte, Robert Prior, et al.
Acta Neuropathologica Communications|July 14, 2019
Reduction of ephrin-A5 aggravates disease progression in amyotrophic lateral sclerosisLaura Rué, Patrick Oeckl, Mieke Timmers, et al.
Neurobiology of Disease|December 4, 2017
Inhibition of histone deacetylase 6 (HDAC6) protects against vincristine-induced peripheral neuropathies and inhibits tumor growthLawrence Van Helleputte, Mandy Kater, Dana P Cook, et al.
Molecular Therapy. Methods & Clinical Development|February 22, 2021
AAV9-mediated gene delivery of MCT1 to oligodendrocytes does not provide a therapeutic benefit in a mouse model of ALSCaroline Eykens, Elisabeth Rossaert, Sandra Duqué, et al.
Nature Neuroscience|August 27, 2015
Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALSAna Jovičić, Jerome Mertens, Steven Boeynaems, et al.
Human Molecular Genetics|July 6, 2016
Genetic ablation of IP3 receptor 2 increases cytokines and decreases survival of SOD1G93A miceKim A Staats, Stephanie Humblet-Baron, Andre Bento-Abreu, et al.
Pageof 66

Showing results (561-570 of 651) with videos related to

Sort By:
Pageof 66
Proceedings of the National Academy of Sciences of the United States of America|September 7, 2007
Astrocytes regulate GluR2 expression in motor neurons and their vulnerability to excitotoxicityPhilip Van Damme, Elke Bogaert, Maarten Dewil, et al.
Brain Communications|May 12, 2021
Intracerebroventricular delivery of vascular endothelial growth factor in patients with amyotrophic lateral sclerosis, a phase I studyPhilip Van Damme, Petra Tilkin, Katarina Jansson Mercer, et al.
Alzheimer'S Research & Therapy|December 14, 2019
EphA4 loss improves social memory performance and alters dendritic spine morphology without changes in amyloid pathology in a mouse model of Alzheimer's diseaseLindsay Poppe, Laura Rué, Mieke Timmers, et al.
Inflammatory Bowel Diseases|November 24, 2015
Genome-Wide Copy Number Variation Scan Identifies Complement Component C4 as Novel Susceptibility Gene for Crohn's DiseaseIsabelle Cleynen, Peter Konings, Caroline Robberecht, et al.
Brain : a Journal of Neurology|February 8, 2018
HDAC6 is a therapeutic target in mutant GARS-induced Charcot-Marie-Tooth diseaseVeronick Benoy, Lawrence Van Helleputte, Robert Prior, et al.
Acta Neuropathologica Communications|July 14, 2019
Reduction of ephrin-A5 aggravates disease progression in amyotrophic lateral sclerosisLaura Rué, Patrick Oeckl, Mieke Timmers, et al.
Neurobiology of Disease|December 4, 2017
Inhibition of histone deacetylase 6 (HDAC6) protects against vincristine-induced peripheral neuropathies and inhibits tumor growthLawrence Van Helleputte, Mandy Kater, Dana P Cook, et al.
Molecular Therapy. Methods & Clinical Development|February 22, 2021
AAV9-mediated gene delivery of MCT1 to oligodendrocytes does not provide a therapeutic benefit in a mouse model of ALSCaroline Eykens, Elisabeth Rossaert, Sandra Duqué, et al.
Nature Neuroscience|August 27, 2015
Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALSAna Jovičić, Jerome Mertens, Steven Boeynaems, et al.
Human Molecular Genetics|July 6, 2016
Genetic ablation of IP3 receptor 2 increases cytokines and decreases survival of SOD1G93A miceKim A Staats, Stephanie Humblet-Baron, Andre Bento-Abreu, et al.
Pageof 66